Ticker
VTGNCompany Name
VISTAGEN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 646K | $ 4.07M | 630.19% |
3/31/2025 | $ 486K | $ 4.32M | 887.86% |
12/31/2024 | $ 698.3K | $ 3.87M | 554.85% |
9/30/2024 | $ 875.7K | $ 3.3M | 376.98% |
6/30/2024 | $ 970.4K | $ 2.77M | 285.75% |
3/31/2024 | $ 1.06M | $ 2.18M | 205.08% |
12/31/2023 | $ 1.04M | $ 2.26M | 216.92% |
9/30/2023 | $ 810.5K | $ 2.5M | 308.53% |
6/30/2023 | $ -359.7K | $ 2.95M | 0% |
3/31/2023 | $ -227.3K | $ 3.34M | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for VISTAGEN THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 3.45M ] / Revenues [ $ 334K ]
(=) SB Comp % [ 1032.87% ]
Minimum
Jun 30, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |